These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 653315

  • 21. The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential.
    Burger R, Zilow G, Bader A, Friedlein A, Naser W.
    J Immunol; 1988 Jul 15; 141(2):553-8. PubMed ID: 2454995
    [Abstract] [Full Text] [Related]

  • 22. Uptake of 125I-labelled C3a by cultured human endothelial cells.
    Denney JB, Johnson AR.
    Immunology; 1979 Feb 15; 36(2):169-77. PubMed ID: 437829
    [Abstract] [Full Text] [Related]

  • 23. Anaphylactic actions of platelet-activating factor.
    Stimler NP, Bloor CM, Hugli TE, Wykle RL, McCall CE, O'Flaherty JT.
    Am J Pathol; 1981 Oct 15; 105(1):64-9. PubMed ID: 6975043
    [Abstract] [Full Text] [Related]

  • 24. Cardiac dysfunction caused by purified human C3a anaphylatoxin.
    del Balzo UH, Levi R, Polley MJ.
    Proc Natl Acad Sci U S A; 1985 Feb 15; 82(3):886-90. PubMed ID: 2579381
    [Abstract] [Full Text] [Related]

  • 25. In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model.
    Hoffmann T, Böttger EC, Baum HP, Messner M, Hadding U, Bitter-Suermann D.
    Clin Exp Immunol; 1988 Mar 15; 71(3):486-92. PubMed ID: 3260158
    [Abstract] [Full Text] [Related]

  • 26. Anaphylatoxins inhibit C2 production.
    Lappin D, Damerau B, Whaley K.
    Clin Exp Immunol; 1983 Nov 15; 54(2):455-60. PubMed ID: 6317240
    [Abstract] [Full Text] [Related]

  • 27. Comparative study on biological effects of the guinea pig complement-peptide C3a and C3a-related synthetic oligopeptides.
    Bitter-Suermann D, Becker S, Meuer S, Schorlemmer HU, Hadding U, Andreatta R.
    Mol Immunol; 1980 Oct 15; 17(10):1257-61. PubMed ID: 7464830
    [No Abstract] [Full Text] [Related]

  • 28. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models.
    Ames RS, Lee D, Foley JJ, Jurewicz AJ, Tornetta MA, Bautsch W, Settmacher B, Klos A, Erhard KF, Cousins RD, Sulpizio AC, Hieble JP, McCafferty G, Ward KW, Adams JL, Bondinell WE, Underwood DC, Osborn RR, Badger AM, Sarau HM.
    J Immunol; 2001 May 15; 166(10):6341-8. PubMed ID: 11342658
    [Abstract] [Full Text] [Related]

  • 29. Inactivation of C3a by a monocarboxypeptidase present in culture supernatants of stimulated guinea pig peritoneal macrophages.
    Kreuzpaintner G, Damerau B, Zimmermann B, Plummer TH, Brade V.
    J Immunol; 1986 May 01; 136(9):3384-9. PubMed ID: 3485689
    [Abstract] [Full Text] [Related]

  • 30. Chemotactic effects of the complement-derived peptides C3a, C3ai and C5a (classical anaphylatoxin) on rabbit and guinea-pig polymorphonuclear leukocytes.
    Damerau B, Grünefeld E, Vogt W.
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Nov 01; 305(2):181-4. PubMed ID: 732894
    [Abstract] [Full Text] [Related]

  • 31. Generation, purification and functional characterization of three C3a anaphylatoxins in rainbow trout: role in leukocyte chemotaxis and respiratory burst.
    Rotllant J, Parra D, Peters R, Boshra H, Sunyer JO.
    Dev Comp Immunol; 2004 Jun 01; 28(7-8):815-28. PubMed ID: 15043949
    [Abstract] [Full Text] [Related]

  • 32. Characterization of C3a receptor-proteins on guinea pig platelets and human polymorphonuclear leukocytes.
    Gerardy-Schahn R, Ambrosius D, Saunders D, Casaretto M, Mittler C, Karwarth G, Görgen S, Bitter-Suermann D.
    Eur J Immunol; 1989 Jun 01; 19(6):1095-102. PubMed ID: 2666143
    [Abstract] [Full Text] [Related]

  • 33. Active site of C3a anaphylatoxin: contributions of the lipophilic and orienting residues.
    Unson CG, Erickson BW, Hugli TE.
    Biochemistry; 1984 Feb 14; 23(4):585-9. PubMed ID: 6608957
    [Abstract] [Full Text] [Related]

  • 34. Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue.
    Huey R, Bloor CM, Kawahara MS, Hugli TE.
    Am J Pathol; 1983 Jul 14; 112(1):48-60. PubMed ID: 6859228
    [Abstract] [Full Text] [Related]

  • 35. Anaphylatoxin C3a induces rapid protein phosphorylation in guinea pig platelets.
    Fukuoka Y, Tachibana T, Yasui A.
    Immunopharmacology; 1994 Jul 14; 28(2):95-104. PubMed ID: 8002292
    [Abstract] [Full Text] [Related]

  • 36. Generation of anaphylatoxin activity related to C3a, by treatment of human serum with the nitrogen nucleophile N2H4 or the chaotrope KSCN.
    von Zabern I, Damerau B, Nolte R, Grünefeld E, Vogt W.
    Scand J Immunol; 1985 Dec 14; 22(6):639-51. PubMed ID: 3937227
    [Abstract] [Full Text] [Related]

  • 37. Human platelet activation by C3a and C3a des-arg.
    Polley MJ, Nachman RL.
    J Exp Med; 1983 Aug 01; 158(2):603-15. PubMed ID: 6604123
    [Abstract] [Full Text] [Related]

  • 38. Synthetic peptides as antagonists of the anaphylatoxin C3a.
    Kretzschmar T, Pohl M, Casaretto M, Przewosny M, Bautsch W, Klos A, Saunders D, Köhl J.
    Eur J Biochem; 1992 Nov 15; 210(1):185-91. PubMed ID: 1446671
    [Abstract] [Full Text] [Related]

  • 39. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.
    Fernandez HN, Henson PM, Otani A, Hugli TE.
    J Immunol; 1978 Jan 15; 120(1):109-15. PubMed ID: 342601
    [No Abstract] [Full Text] [Related]

  • 40. Anaphylatoxin-mediated regulation of human and murine immune responses.
    Morgan EL, Weigle WO, Hugli TE.
    Fed Proc; 1984 Jul 15; 43(10):2543-7. PubMed ID: 6610569
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.